Cholangiocarcinoma CT

Jump to navigation Jump to search

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangiocarcinoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangiocarcinoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangiocarcinoma CT

CDC on Cholangiocarcinoma CT

Cholangiocarcinoma CT in the news

Blogs on Cholangiocarcinoma CT

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cholangiocarcinoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

  • [Location] CT scan may be helpful in the diagnosis of cholangiocarcinoma. Findings on CT scan suggestive of cholangiocarcinoma include:
    • The rate and extent of enhancement depends on the degree of central fibrosis.
    • Capsular retraction may be observed.
    • Bile ducts distal to the mass are typically dilated.
    • Narrowing of the portal veins or hepatic veins is observed.
    • Lobar or segmental hepatic atrophy is usually associated with vascular invasion

References

Template:WH Template:WS